Treatment of psychic disorders accompanying myasthenia gravis (Grandaxin, a new, non-relaxant tranquillizer).
D000328:Adult; D014151:Anti-Anxiety Agents / Q000627:therapeutic use*; D001569:Benzodiazepines; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D008297:Male; D001523:Mental Disorders / Q000188:drug therapy* / Q000209:etiology; D008875:Middle Aged; D009157:Myasthenia Gravis / Q000150:complications*
D014151:Anti-Anxiety Agents; D001569:Benzodiazepines